Two Sigma Investments
ARTL icon

Two Sigma Investments’s Artelo Biosciences ARTL Stock Holding History

Two Sigma Investments’s Portfolio ARTL Stock Details ARTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,890
Closed -$25.2K – 4572
2025
Q4 		$25.2K Buy
+6,890
New +$53.4K ﹤0.01% 3981
2022
Q4 		– Sell
-589
Closed -$37K – 2789
2022
Q3 		$37K Buy
+589
New +$47.4K ﹤0.01% 2339
2021
Q3 		– Sell
-607
Closed -$195K – 4219
2021
Q2 		$195K Buy
+607
New +$207K ﹤0.01% 3789

Other funds holding ARTL

AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
KCM
Kathmere Capital Management Wayne, Pennsylvania $1.89B AUM 26.04% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $2.68B AUM 34.39% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Two Sigma Investments's ARTL Position: Q1 2026 in Review

Two Sigma Investments sold out of Artelo Biosciences (ARTL) in Q1 2026, closing a stake of 6,890 shares — an estimated $25.2K sold.

Two Sigma Investments first reported a position in ARTL in Q2 2021 and held it in 3 quarters. The position peaked at $195K in Q2 2021. 11 funds tracked by Wall St. Rank hold ARTL as of Q1 2026.

  • Two Sigma Investments reported no remaining Artelo Biosciences position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Investments sold 6,890 Artelo Biosciences shares in Q1 2026, an estimated $25.2K.
  • Two Sigma Investments first reported a position in Artelo Biosciences in Q2 2021 and held it in 3 quarters.
  • Two Sigma Investments's Artelo Biosciences position peaked at $195K in Q2 2021.
  • 11 funds tracked by Wall St. Rank held Artelo Biosciences as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.